Gilead Sciences Inc
NASDAQ:GILD
Gilead Sciences Inc
NASDAQ:GILD
Price:
67.01 USD
-0.95%
Market Closed
Updated:
May 16, 2024
Gilead Sciences Inc
EPS (Diluted)
|
Gilead Sciences Inc
EPS (Diluted) Peer Comparison
Comparables:
ABBV
AMGN
MRNA
VRTX
REGN
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
EPS (Diluted)
$0
|
CAGR 3-Years
18%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-18%
|
|
|
Abbvie Inc
NYSE:ABBV
|
EPS (Diluted)
$2
|
CAGR 3-Years
0%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
EPS (Diluted)
$7
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
1%
|
|
|
Moderna Inc
NASDAQ:MRNA
|
EPS (Diluted)
-$15
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-62%
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
EPS (Diluted)
$13
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
EPS (Diluted)
$33
|
CAGR 3-Years
-3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
25%
|
See Also
What is Gilead Sciences Inc's EPS (Diluted)?
EPS (Diluted)
0.4
USD
0.4
USD
Based on the financial report for Mar 31, 2024, Gilead Sciences Inc's EPS (Diluted) amounts to 0.4 USD.
What is Gilead Sciences Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-18%
-18%
Over the last year, the EPS (Diluted) growth was -91%. The average annual EPS (Diluted) growth rates for Gilead Sciences Inc have been 18% over the past three years , -39% over the past five years , and -18% over the past ten years .
You don't have any saved screeners yet
